GENETIC VECTORS INC
NT 10-Q, 1998-11-17
PHARMACEUTICAL PREPARATIONS
Previous: INTENSIVA HEALTHCARE CORP, SC 14D9, 1998-11-17
Next: KABELMEDIA HOLDING AG, 6-K, 1998-11-17




                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                  FORM 12B-25

                                                 Commission File Number 0-21739

                          NOTIFICATION OF LATE FILING

      (Check One): [ ] Form 10-K   [ ] Form 11-K   [ ] Form 20F   [X] Form 10-Q

[ ] Form N-SAR

      For Period Ended:  SEPTEMBER 30, 1998

[  ] Transition Report on Form 10-K       [  ] Transition Report on Form 10-Q

[  ] Transition Report on Form 20-F       [  ] Transition Report on Form N-SAR

[  ] Transition Report on Form 11-K


      For the Transition Period Ended:
                                      ------------------------------------------

      READ ATTACHED  INSTRUCTION  SHEET BEFORE  PREPARING FORM.  PLEASE PRINT OR
TYPE.

      Nothing in this form shall be construed to imply that the  Commission  has
verified any information contained herein.

      If the  notification  relates to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates:

- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

                                    PART I
                            REGISTRANT INFORMATION

Full name of registrant: GENETIC VECTORS, INC.

Former name if applicable: N/A

Address of principal  executive  office  (Street and number):  
                              5201 N.W. 77TH AVENUE, SUITE 100

City, state and zip code:  MIAMI, FLORIDA  33166



<PAGE>


                                    PART II
                           RULE 12B-25 (B) AND (C)

      If the subject  report could not be filed without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check appropriate box.)

[X]   (a) The reasons  described in  reasonable  detail in Part III of this form
      could not be eliminated without unreasonable effort or expense;

[X]   (b) The subject annual report,  semi-annual  report,  transition report on
      Form 10-K,  20-F,  11-K or Form N-SAR, or portion thereof will be filed on
      or before the 15th calendar day following the  prescribed due date; or the
      subject  quarterly  report or  transition  report on Form 10-Q, or portion
      thereof will be filed on or before the fifth  calendar day  following  the
      prescribed due date; and

[ ]   (c) The  accountant's  statement  or  other   exhibit  required   by  Rule
      12b-25(c) has been attached if applicable.


<PAGE>



                                   PART III
                                  NARRATIVE

      State below in reasonable  detail the reasons why Form 10-K,  11-K,  10-Q,
N-SAR or the  transition  report  portion  thereof could not be filed within the
prescribed time period. (Attach extra sheets if needed.)

      The Registrant's  President and sole accounting officer has been traveling
both  internationally  and  domestically  to attend meetings that the Registrant
could not reschedule without  unreasonable effort or expense.  In addition,  the
Registrant's  President  and sole  accounting  officer has devoted a significant
amount of his  attention  and the  Registrant's  resources  to  capital  raising
activities.  As reported in Form 10-QSB for the quarter ended June 30, 1998, the
Registrant  had projected  that the proceeds from its initial  public  offering,
which  closed on December 26, 1996,  would last  through  November of 1998.  The
failure of the  Registrant  to raise  additional  capital by the end of November
1998 may  result in it  suspending  its  business  activities  to  preserve  its
existing  capital until an alternative  source of capital can be located,  if at
all. These activities have resulted in delays in preparing the financial reports
necessary to prepare this quarter's Form 10-QSB. Due to these circumstances, the
Registrant  respectfully  requests  an  extension  of the  filing  date  for its
quarterly report on Form 10-QSB for the quarter ending September 30, 1998.


                                    PART IV
                              OTHER INFORMATION

      1.  Name and  telephone  number of  person  to  contact  in regard to this
notification:

            Mead M. McCabe, Jr.        (305)                716-0000
            -------------------     -----------       ------------------
            (Name)                  (Area code)       (Telephone number)

      2.  Have all other periodic reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment  Registrant
Act of 1940 during the  preceding 12 months or for such shorter  period that the
registrant was required to file such report(s) been filed?
If the answer is no, identify report(s).

                                                [X]  Yes  [  ] No

      3.  Is it anticipated that any significant change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

                                                [X]  Yes  [  ] No

      If so: attach an explanation of the anticipated  change,  both narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.

      See Attachment.


                                       2

<PAGE>



                            GENETIC VECTORS, INC.
                 (Name of registrant as specified in charter)

Has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.




Date:  November 17, 1998               By:  /s/ Mead M. McCabe, Jr.
                                            ------------------------------
                                            Mead M. McCabe, Jr., President


         INSTRUCTION.  The form may be signed  by an  executive  officer  of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the   registrant  by  an  authorized
representative   (other   than   an   executive   officer),   evidence   of  the
representative's  authority to sign on behalf of the  registrant  shall be filed
with the form.

                                  ATTENTION

      Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).


                             GENERAL INSTRUCTIONS

      1.  This  form is  required  by  Rule  12b-25  of the  General  Rules  and
Regulations under the Securities Exchange Act of 1934.

      2.  One  signed  original  and  four  confirmed  copies  of this  form and
amendments  thereto must be completed and filed with the Securities and Exchange
Commission,  Washington,  DC 20549,  in accordance  with Rule 0-3 of the General
Rules and Regulations under the Act. The information  contained in or filed with
the form will be made a matter of the public record in the Commission files.

      3. A manually  signed  copy of the form and  amendments  thereto  shall be
filed with each national securities exchange on which any class of securities of
the registrant is registered.

      4. Amendments to the  notifications  must also be filed on Form 12b-25 but
need not restate information that has been correctly  furnished.  The form shall
be clearly identified as an amended notification.

      5.  ELECTRONIC  FILERS.  This form shall not be used by electronic  filers
unable to timely file a report  solely due to  electronic  difficulties.  Filers
unable to submit a report within the time period  prescribed due to difficulties
in  electronic  filing  should  comply  with  either  Rule  201 or  Rule  202 of
Regulation  S-T or apply for an adjustment in filing date pursuant to Rule 13(b)
of Regulation S-T.


                                       3

<PAGE>



                                  ATTACHMENT
                      (CHANGES IN RESULTS OF OPERATIONS)


      The  Registrant  expects  to  report a  significant  decrease  in its cash
position from the corresponding  period for the last fiscal year. As reported in
Form 10-QSB for the quarter ended June 30, 1998,  the  Registrant  had projected
that the proceeds from its initial public offering, which closed on December 26,
1996, would last through November of 1998. As of the date hereof, the Registrant
has  not  raised  any  significant  additional  capital.  In the  quarter  ended
September  30,  1997,  the   Registrant   had  cash  and  cash   equivalents  of
approximately $2.8 million (of which  approximately $1.9 million was invested in
a  certificate  of  deposit).  In the quarter  ended  September  30,  1998,  the
Registrant  expects to report cash and cash  equivalents  equal to approximately
$500,000.  The Registrant notes that its cash position is lower than $500,000 on
the date of this filing as it has continued operations since September 30, 1998.
Without  additional  capital,  the  Registrant  may need to suspend its business
activities.



                                       4



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission